Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this study is to investigate the effects of Vitamin D3 combined with Folic Acid on mild cognitive impairment (MCI). Participants aged 50 to 70 years with MCI will be randomly assigned to three groups: a low-dose Vitamin D3 plus Folic Acid group, a high-dose Vitamin D3 plus Folic Acid group, and a placebo group. The intervention will last for 6 months. The main goal is to observe whether this nutritional intervention can improve or delay the decline of cognitive function.
Epistemonikos ID: 345057663c5b0ada3138ee09afc4d75a3179d1f6
First added on: Mar 21, 2026